Increasing rates of in vitro resistance to ciprofloxacin and norfloxacin in isolates from urine specimens

This publication has 10 references indexed in Scilit:

• Ciprofloxacin therapy of respiratory tract infection withPseudomonas aeruginosa
  European Journal of Clinical Microbiology & Infectious Diseases, 1988
• Comparison of the Cobas-Bact five-hour susceptibility testing system with the NCCLS agar diffusion and dilution methods
  European Journal of Clinical Microbiology & Infectious Diseases, 1988
• Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin
  Antimicrobial Agents and Chemotherapy, 1988
• Susceptibility of Hong Kong isolates of methicillin-resistant Staphylococcus aureus to antimicrobial agents
  Journal of Antimicrobial Chemotherapy, 1988
• Development of Resistance in Pseudomonas aeruginosa to Imipenem, Norfloxacin, and Ciprofloxacin During Therapy: Proof Provided by Typing with a DNA Probe
  The Journal of Infectious Diseases, 1988
• Evaluation of the cobas bact automated system for susceptibility testing of enterobacteriaceae, pseudomonas aeruginosa, and enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards
  Infection, 1988
• Oral ciprofloxacin in resistant urinary tract infections.
  1987
• Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women
  Journal of Antimicrobial Chemotherapy, 1986
• Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria
  Journal of Antimicrobial Chemotherapy, 1986
• Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations
  Antimicrobial Agents and Chemotherapy, 1984